Sharemaestro Newsreel

3 Stocks to Watch When Treasury Yields Top 5%

When the 10 year Treasury yield jumps above 5%, borrowing costs reset, valuation math changes and the usual playbook for stocks starts to look shaky. Some investors rush to the exits. Others hunt for ways to turn rising volatility into a tool, not a …

Is Nexi (BIT:NEXI) Fairly Valued After Its FTSE All World Index Exit?

Nexi (BIT:NEXI) was removed from the FTSE All-World Index (USD) on 19 September 2026, a change that can influence how index-tracking funds and benchmark-aware investors treat the stock. Nexi's share price has been volatile, with a 17.78% 90 day share price return followed by …

Cintas (CTAS) Stock May Be 6% Undervalued Following Raised Guidance

Cintas has delivered a powerful 5 year share price run, and recent news on its growth plans has kept investors focused on what that move implies for the company's underlying cash flows. With the stock now trading around US$197.68 after a mixed shorter term …

Ist die Cintas-Aktie (CTAS) nach der Anhebung der Prognose bereits vollständig bewertet?

Alten (ENXTPA:ATE) Stock May Still Offer Value On Earnings Strength

Alten has seen its share price move around in recent years, and that naturally puts the focus on whether today's valuation is supported by the consulting group's earnings power. With investors watching both recent setbacks and shorter term rebounds, the question now is how …

3 Stocks Tied To Apple And Nvidia Supply Chain Demand

Market leadership has rarely felt this concentrated, with Apple and Nvidia together now carrying more than 15% of the S&P 500 and pulling a tight circle of suppliers into the spotlight. That kind of focus can magnify both upside and risk, which is exactly …

Alten (ENXTPA:ATE) Could Be 26% Undervalued On Its Latest Valuation Read

Alten (ENXTPA:ATE) has drawn fresh attention after a recent price move, with the shares closing at €70.8. Investors now have updated return figures to reassess the engineering and IT consultancy's profile. The recent pullback, with a 1-day share price return down 2.48%, comes after …

Is Cintas a Buy After Its Latest Earnings Report?

Cintas Growth Momentum Supports Higher Outlook, UBS Says

Marie Brizard Wine & Spirits: First Half 2026 earnings

Marie Brizard Wine & Spirits Charenton-le-Pont, 24th September 2026 H1 2026 earnings H1 2026 earnings down amid a globally challenging market environment Business resilience in France, particularly in the second quarter EBITDA1 of €4.9m in H1 2026, down €0.9m from €5.9m in H1 2025 …

TP Appoints Benoit Gabelle as Group Chief Financial Officer

PARIS, September 24, 2026--(BUSINESS WIRE)--Regulatory News: TP (Paris:TEP), a global leader in digital business services, today announced the appointment of Benoit Gabelle as Group Chief Financial Officer, effective immediately. Benoit Gabelle has served as Interim Group Chief Financial Officer since March 2026 when Jorge …

Cintas Shows Strong Execution in Q1, RBC Says

European Cybersecurity Stocks Gaining Attention As Nato Threats Put Critical Networks In Focus

European security risk has moved from theory to front page as Danish intelligence warns that a Russian move against a Nato country is possible within months, and that raises the stakes for anything tied to critical infrastructure and cybersecurity. Hybrid threats like cyber intrusions …

Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth?

Recursion Pharmaceuticals RXRX continues to leverage its AI-native drug discovery platform through a broad portfolio of pharma, technology and data partnerships. These collaborations are expanding its pipeline while generating non-dilutive funding to support R&D. As of the second quarter of 2026, RXRX had received …

All You Need to Know About RELX (RELX) Rating Upgrade to Buy

RELX PLC (RELX) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. A company's changing …

Chronic Kidney Disease Market: 5 Emerging Therapies to Watch as the Treatment Landscape Expected to Evolve by 2036 | DelveInsight

A diversified late-stage pipeline encompassing endothelin receptor antagonists, aldosterone synthase inhibitors such as lorundrostat, APOL1 inhibitors including MZE829, and cell therapy approaches such as rilparencel is poised to intensify competition, with each modality addressing mechanisms that complement the established SGLT2 inhibitor/MRA backbone. The CKD …

Cintas (CTAS) Q1 2027 Earnings Call Transcript

This article first appeared on GuruFocus. Total Revenue: $3.01 billion, up 10.9% year-over-year; first time reaching $3 billion in a quarter. Organic Growth Rate: 8.9%, adjusting for acquisitions, FX, and workday differences. Diluted EPS: $1.36, up 13.3% year-over-year. Adjusted Diluted EPS: $1.39, up 15.8% …

Wolters Kluwer Survey: Patients’ Concerns About Medical AI Reveal Deep Trust Gaps Across Age, Gender, and Geography

New Future Ready Healthcare insights reveal how patient concerns about data privacy, validation, and accuracy are impacting adoption KEY TAKEAWAYS Wolters Kluwer Health's 2026 Future Ready Healthcare survey finds that U.S. patients use AI mainly to research medication side effects, diagnoses, and health information—but …

Wolters Kluwer injects an AI-boost to compliance and legal documentation with Expert AI additions to CT Corporation's hCue

Backed by CT Corporation's business entity management expertise, the Expert AI-powered solutions can help teams work smarter, faster, and with greater confidence NEW YORK, September 24, 2026--(BUSINESS WIRE)--Wolters Kluwer Financial & Corporate Compliance today announced the launch of CT® hCue® Expert AI Document Extract …

Cintas Corporation Q1 2027 Earnings Call Summary

UBS Raises Price Target on Cintas to $235 From $230, Keeps Buy Rating

Baird Adjusts Price Target on Cintas to $222 From $214, Keeps Outperform Rating

Goldman Sachs Adjusts Price Target on Cintas to $239 From $231, Keeps Buy Rating

Wolters Kluwer integrates Libra AI workflows into monKEY for Belgian tax professionals

The add-in of Libra by Wolters Kluwer brings AI capabilities directly into monKEY's trusted tax research environment and marks an important milestone in further expanding Libra's presence across different customer segments ALPHEN AAN DEN RIJN, Netherlands, September 24, 2026--(BUSINESS WIRE)--Wolters Kluwer Legal & Regulatory …

Cintas Raises Full-Year Outlook Following Fiscal First-Quarter Beat

Cintas (CTAS) increased its full-year financial guidance as the uniform supplier reported better-tha PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? …

Cintas Q1 Earnings Call Highlights

Key Points Interested in Cintas Corporation? Here are five stocks we like better. Cintas delivered record first-quarter results: Revenue rose 10.9% year over year to $3.01 billion, organic growth reached 8.9%, and adjusted diluted EPS increased 15.8% to $1.39. Growth and profitability were broad-based: …

Compared to Estimates, Cintas (CTAS) Q1 Earnings: A Look at Key Metrics

For the quarter ended August 2026, Cintas (CTAS) reported revenue of $3.01 billion, up 10.9% over the same period last year. EPS came in at $1.39, compared to $1.20 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $2.97 …

Cintas (CTAS) Q1 Earnings and Revenues Surpass Estimates

Cintas (CTAS) came out with quarterly earnings of $1.39 per share, beating the Zacks Consensus Estimate of $1.35 per share. This compares to earnings of $1.2 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

Cintas beats estimates but stock edges lower

Investing.com -- Cintas Corporation (NASDAQ: CTAS) reported first-quarter results that exceeded analyst expectations, though shares fell 1.2% premarket. Still guessing which names to buy? Our AI rebuilds its stock picks at the start of every month. The list is beating the market by 120%. …

Cintas Corporation hebt Gewinnprognose für das gesamte Geschäftsjahr 2027 an

Cintas Fiscal Q1 Adjusted Earnings, Revenue Rise; Raises Fiscal 2027 Guidance

Cintas-Ergebnisse für das 1. Quartal des Geschäftsjahres 2027: Margenexpansion stützt EPS-Wachstum von 13 %

Cintas: Fiscal Q1 Earnings Snapshot